|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/5575 | |
| A61P 13/12 |
| (11) | Number of the document | 1696932 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04814318.4 |
| Date of filing the European patent application | 2004-12-16 | |
| (97) | Date of publication of the European application | 2006-09-06 |
| (45) | Date of publication and mention of the grant of the patent | 2009-09-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2004/042119 |
| Date | 2004-12-16 |
| (87) | Number | WO 2005/058329 |
| Date | 2005-06-30 |
| (30) | Number | Date | Country code |
| 529621 P | 2003-12-16 | US |
| (72) |
WADE, Michael, United Therapeutics Corp., US
JEFFS, Roger, Andrew, United Therapeutics Corp., US
BRONSTEIN, Kathryn, US
STROOTMAN, Deborah, United Therapeutics, US
|
| (73) |
United Therapeutics Corporation,
1735 Connecticut Avenue, N.W. Third Floor, Washington, DC 20009,
US
|
| (54) | USE OF TREPROSTINIL TO IMPROVE KIDNEY FUNCTIONS |
| USE OF TREPROSTINIL TO IMPROVE KIDNEY FUNCTIONS |